MedTrace Logo

Study on Preventing Anemia in Children in Ghana

NCT00301054 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 872

Last updated 2006-05-29

No results posted yet for this study

Summary

A study that seeks to establish an effective way of preventing anaemia in children at the community level using two known interventions - Iron supplementation and or antimalarial. Children recruited into the study will be assigned to four groups. Those receiving Placebo and Iron, those receiving Placebo and Antimalarial, those receiving Placebo and Antimalarial and those receiving double placebo. The children will be followed up over a period of nine months and their haemoglobin concentration, malaria parasites in their blood and their weight and height will be assessed.

Conditions

  • Anaemia in Children

Interventions

DRUG

Ferrous sulphate

DRUG

Sulphadoxine-Pyrimethamine

Sponsors & Collaborators

  • Netherlands Overseas Agency

    collaborator AMBIG

  • Ghana Health Services

    lead OTHER_GOV

Principal Investigators

  • ANTHONY A OFOSU, MBChB, MPH · GHANA HEALTH SERVICE BEREKUM DISTRICT

  • DONNA M DENNO, MD, PAEDS · UNIVERSITY OF WASHINGTON MEDICAL CENTER, SEATTLE, USA

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
6 Months
Max Age
30 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-06-30
Completion
2006-04-30

Countries

  • Ghana

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00301054 on ClinicalTrials.gov